SCCR22: Brazilian interventions in favor of a Treaty on exceptions and limitations to copyright for persons with disabilities
Mr Chairman,It is with much pleasure that Brazil notes that we started this second week of the XXII SCCR with a text on the table that is co-sponsored by Argentina, Australia, Brazil, Ecuador, México, Paraguay, and the United States and that is also supported by the EU.
Derecho a la Vida Privada en las Negociaciones del TPP
La Oficina del Representante Comercial de los Estados Unidos (USTR) ha declarado su intención de tener completadas sus propuestas sobre protección de la propiedad intelectual a comienzos de la próxima ronda de negociaciones del TPP en Vietnam, del 20 al 24 de junio de 2011. En su rápida agenda, los negociadores del TPP han anunciado que ellos esperan concluir el acuerdo para el encuentro de los miembros del Foro de Cooperación Económica Asia-Pacífico, a realizarse en Hawaii del 8 al 13 de noviembre de 2011. Continue Reading
U.S. employment and wages in 14 information sectors
I have another blog that deals with U.S. employment data from the information sector. This one provides May 2010 employment and wage data from fourteen 4- and 5-digit NAICS industry groups in the “Information Sector.”
Notes on the data
Right to Privacy in Trans-Pacific Partnership (TPP ) Negotiations
The Office of the U.S. Trade Representative (USTR) has declared an intention to have all its proposals on intellectual property protections by the commencement of the next round of TPP talks in Vietnam June 20-24, 2011. On a fast timetable, TPP negotiators have already announced that they want to finalize TPP by the summit meetings of the members of the Asia-Pacific Economic Cooperation on November 8-13, 2011 in Hawaii. The TPP will impact health, access to knowledge, and without the necessary safeguards, the right to privacy.
Non paper distributed at SCCR 22 at 1pm on Friday, on disabilities
In a major breakthrough on the WIPO negotiations on copyright exceptions for persons with disabilities, at around 1pm today, a non-paper “resulting from informal discussions among Argentina, Brazil, Ecuador, the European Union and its Member States, Mexico, Paraguay and the United States of America” was distributed at the WIPO SCCR 22.
A copy of the document is available here:
/wp-content/uploads/text_distributed_friday_1pm.doc
1 Report from SCCR 22 discussions of WIPO treaty for persons who are blind or have other disabilities
Members of the WBU delegation at WIPO SCCR 22 June 16, 10 am: There are good news and less good news to report from Geneva. While overall, things have moved in positive directions, with the US and the EU engaged in very constructive negotiations with Brazil and other treaty sponsors, there are still many frustrations. Continue Reading
White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs)
Pharmaceutical global R&D was 7.9 percent of sales in 2010
Using industry assertions of R&D spending, pharmaceutical related R&D spending by the private sector was less than 8 percent of global sales in 2010.
These are the data:
2010 Global R&D by all private companies: – $67.4 billion
Source: Page 2 of the 2011 PhRMA industry profile
http://report.nih.gov/investigators_and_trainees/acd_bwf/pdf/Phrma_Industry_Profile_2011.pdf2010 Global sales – $856 billion
Continue ReadingDraft of the Political Declaration on HIV and AIDS disappoints public health NGOs
FDA New drug approvals for 2011, through June 6
This is a report from the FDA on 2011 new molecular entities (NMEs) approvals, through June 6, 2011. The total number of FDA approvals during that same period was 150. So far, 16 NMEs have been approved in five months, a sharp increase in approvals over the same period 2010.
6 NMEs NDAs were considered priorities
8 NDAs that were considered standard approvals
2 BLA (biologic products) that were not classified.
- NMEs were 10.7 percent of all approvals.
- The NME priority NDAs were 4 percent of FDA approvals.
